Similar articles

• [Cardiotoxicity of doxorubicin in children].

  Pilon JW, Naeff MS, Taminiau JA. Pilon JW, et al. Ned Tijdschr Geneeskd. 1984 Jul 14;128(28):1339-43. Ned Tijdschr Geneeskd. 1984. PMID: 6482993 Dutch. No abstract available.
• [Adriamycin cardiomyopathy].

  Nilles M, Wehr M, Köhler F. Nilles M, et al. Med Welt. 1984 Jan 27;35(4):103-8. Med Welt. 1984. PMID: 6700420 German. No abstract available.
• Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.

  Khan M, Shobha JC, Mohan IK, Naidu MU, Sundaram C, Singh S, Kuppusamy P, Kutala VK. Khan M, et al. Phytother Res. 2005 Dec;19(12):1030-7. doi: 10.1002/ptr.1783. Phytother Res. 2005. PMID: 16372368
• [Cardiological monitoring of patients treated with doxorubicin].

  Mahaux V, Demoulin JC, Closon MT, Jardon-Jeghers C, Vivario M, Kulbertus H. Mahaux V, et al. Rev Med Liege. 1988 Jun 15;43(12):449-55. Rev Med Liege. 1988. PMID: 3041526 Review. French. No abstract available.
• [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].

  Rubio JA, Pulpón LA, Cavero MA, Oteo JF, Maicas C, Silva L, Serrano-Fiz S, Burgos R, Artaza M, Téllez G, et al. Rubio JA, et al. Rev Esp Cardiol. 1994 Nov;47(11):777-9. Rev Esp Cardiol. 1994. PMID: 7800910 Review. Spanish.